S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC). X Whil...

Healthcare And Biotech Outperform As Recession Fears Heat Up

Stocks fell sharply in September to this bear market’s new lows. Getty Images September lived up to its billing as a lackluster month for the stock market, as the S&P 500 lost another 9.1% t...

Pay No Attention To Biden’s Biotech Bluster

BOSTON, MA – SEPTEMBER 12: U.S. President Joe Biden delivers remarks at the John F. Kennedy Library … [+] and Museum on his Cancer Moonshot Initiative on September 12, 2022 in Boston, Mass...

Radical Research Advance To Boost Biotech Industry’s Health

DNA Helix Bettmann Archive An Alphabet (GOOGL) unit used artificial intelligence to disrupt the way new drugs are discovered. This is the best way for investors to take advantage. DeepMind announced J...

This Infection-Fighting Biotech Is Recovering Nicely

The stock and fortunes of antibiotic-developer Spero Therapeutics (SPRO)  looked like they were about to get flushed down the toilet … until last week. The company’s primary and only signi...

In The Fed’s Inflation Fight, Biotech May Be The First Casualty

Serious thought should be given to the effect the anticipated Federal Reserve 0.75% rate hike will have on the biotechnology industry and consequently on the health of the nation. Given we are in the ...

Biotech Stocks Notch A Blazing Path In 2022 — Why The Good Times Aren’t Over

The stock market is struggling, yet scores of biotech stocks are surging like it’s a new bull market, all the way from top-rated Catalyst Pharmaceuticals, through such heavy hitters as Neurocrin...

The Biden Biotech Boom Is About To Send This 6.8% Dividend Soaring

Heap of medical pills in white, blue and other colors. Pills in plastic package. Concept of … [+] healthcare and medicine. getty Some major—and almost totally ignored—news from Washington, D.C.,...

Hacking Capitalism With Nature

Through biotech, the same patterns of growth that got our planet into a mess can get us out. getty Through bio-fabrication and synthetic biology, we can heal our planet while increasing economic vital...

Oppenheimer Says Biotech Stocks Look a Bit Brighter Right Now; Here Are 2 Names to Consider

The biotech sector, like most sections of the market, took a sound beating in the year’s first half. Recently, however, the segment’s performance has improved, and that has helped the NASDAQ Biotechno...

Biotech, Tanker Stocks Hit New Highs, Top Bullish Patterns

Stocks striking new highs are still rare to find as several stocks, sectors and indexes finally approach their 50-day moving average. But rare-disease-drug maker Catalyst Pharmaceuticals (CPRX) and Te...

Morgan Stanley just upgraded this large cap biotech stock

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is now back to near its year-to-date high but a Morgan Stanley analyst says the stock is not done pleasing its investors yet. Regeneron stock has another 2...

These Four Biotech Stocks Sparkle In IBD 50

Four biotech stocks are hovering near the top of the IBD 50 list of growth stocks, putting on a show of relative strength leadership in this hot industry group. One is near a buy point of a new base, ...

Not Your Hot-Tip-From-Your-Brother-In-Law Biotech Stock

Better-than-expected Covid-19 vaccine sales pushed Moderna past Wall Street’s 2022 second-quarter … [+] forecasts. The company said Wednesday, Aug. 3, 2022, that its Spikevax vaccine brought in ...

Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech

A silhouette of hands in medical gloves hold a medical syringe and a vial in front of Fosun Pharma’s … [+] logo. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Imag...

Biotech Stocks: The Top 5 To Watch Amid A Blazing Hot Run

Biotech stocks have been on a roller-coaster ride and they’re riding a crest again. X In 2021 the industry was thrust into the pandemic limelight as Pfizer (PFE) and its partner BioNTech (BNTX),...

Cathie Wood Watch: Ark Buys Big Into Biotech

Renowned investor Cathie Wood, chief executive of Ark Investment Management, on Monday purchased a heavy dose of biotechnology stocks. All valuations below are as of Monday’s close. Ark funds bought 8...

Merck in Advanced Talks to Buy Biotech Company Seagen

The regulatory concerns associated with the potential deal between Merck and Seagen may attract antitrust scrutiny from regulators.  American multinational pharmaceutical company Merck & Co Inc (N...

These 4 Stocks Are Bouncing Off The June Lows

Upward. getty These 4 stocks are bouncing so well off of their June lows that they’ve each managed to establish new 50-day highs. That is, they’re higher now than at anytime in the past 50 days of tra...

Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion

Text size New Jersey-based Merck has a market value of more than $234 billion. Michael Vi/Dreamstime Merck & Co  is in advanced talks to buy Seagen in a deal that could value the cancer biotech at...

Investments in U.S.-based biotech firms shrink 46% YoY

A notable increase in venture financing in the U.S. biotech private sector was seen in 2021, with company stocks only increasing. Thus it is conceivable to make the case that a bubble was growing in t...

Biotech stocks will ‘outperform’ in the balance of 2022: Fahmy

A new bull market is unlikely until the U.S. Federal Reserve starts to go easy on the interest rates. Still, there are opportunities that could be rewarding in the back half of 2022. Fahmy’s bul...

Biotech Says It Can Program Life To Make New Stuff. Is That True?

393282 04: A digital representation of the human genome August 15, 2001 at the American Museum of … [+] Natural History in New York City. Each color represents one the four chemical compenents o...

This biotech stock is up 100% on Tuesday: here’s the catalyst

Pfizer Inc (NYSE: PFE), on Tuesday, doubled down on its partnership with Valneva SE (NASDAQ: VALN) to develop a vaccine for Lyme disease. Shares of the French biotech firm are up nearly 100% this morn...

3 NASDAQ Stocks Make New Highs While The NASDAQ Sinks Lower

Manhattan, New York. December 23, 2020. People walking in front of Nasdaq market site located at 4 … [+] Times Square. getty While most NASDAQNDAQ stocks got sold and kept making lower lows, 3 s...

The Days of Big Pharma Are Over. Big Biotech Is on Its Way.

W hen GlaxoSmithKline spins off its enormous division selling drugstore staples like Advil and Tums next month, it will represent more than just the latest shuffling of assets among corporate giants. ...

Five Beaten-Up Biotech Stocks Saw Big Share Purchases

Text size Biotech stocks Kymera, Cullinan Oncology, Repare, Iovance, and Kodiak Sciences are all in the red so far this year, but they’ve seen large stock buys. Dreamstime Biotech stocks have taken so...

this ‘underrated’ biotech firm can weather a recession

The iShares Biotechnology ETF (IBB) is still down nearly 25% for the year, but Alger’s portfolio manager says there are opportunities within this space that can weather a recession. Zhang’s favourite ...

AI-Powered Hong Kong Biotech Startup Raises $60 Million From Top VCs Including B Capital, Qiming

Getty Hong Kong-based biotech startup Insilico Medicine has raised $60 million in Series D funding from investors including Singapore billionaire Eduardo Saverin’s B Capital Group, private equit...

Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.

Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...

Cathie Wood Watch: Ark Piles Into Nvidia, Buys an AI Biotech

Renowned investor Cathie Wood, chief executive of Ark Investment Management, for a second day bought big into one of the world’s biggest semiconductor makers after staying away from it for at least se...

I’m ‘Following Up’ on a Biotech Trade With Attractive Potential

Just before noon ET on Friday, May 27, Doug Kass posted the following in his Daily Diary on Real Money Pro:  “I added to SPDR S&P Biotech ETF (XBI)  this morning. And I sold some attractivel...